The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -51.32%.However, over the last six months, we can see a stronger performance of -49.57%. Over the last 30 days, the price of ONCY has leaped by -17.48%. And in the last five days, it has surged by 29.30%.
Oncolytics Biotech, Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $1.53 on 10/07/24 and a low of $0.33 for the same time frame on 06/06/25.
52-week price history of ONCY Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Oncolytics Biotech, Inc’s current trading price is -70.93% away from its 52-week high, while its distance from the 52-week low is 36.53%. The stock’s price range during this period has varied between$0.33 and $1.53. The Oncolytics Biotech, Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.21 million for the day, a figure considerably higher than their average daily volume of 0.49 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Oncolytics Biotech, Inc (ONCY) has experienced a quarterly decline of -30.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 39.51M and boasts a workforce of 28 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
ONCY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ONCY stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.11.
